SpotLight™ offers an unparalleled understanding of complex health profiles.
Disruptive Innovation
SpotLight™ eliminates the need for needles, swabs, or chemical reagents, replacing them with a single, 30-second fingertip scan. This approach brings advanced health monitoring to any environment, from airports, border crossings, schools and clinics to remote communities.
Non-invasive
SpotLight™ is a truly non-invasive screening experience, unlike current invasive methods that require a sample of blood, urine, saliva, stool or tissue.
Expandable Platform
SpotLight™ has the ability to respond to emerging health challenges with timely and seamless algorithm uploads without the need for hardware modifications.
Environmentally Friendly
SpotLight™ eliminates hazardous chemical reagent waste and the environmental and health risks associated with current health monitoring methods.
Real-time Health Data
SpotLight™ provides immediate results, verses the days or weeks required for private clinics to have blood or stool samples processed by domestic or off-shore labs.
No Expiry Date
SpotLight™ avoids the cost and logistical challenges arising from the expiry of chemical reagent-based tests, as observed during the COVID-19 pandemic.
Low Cost Per Test
SpotLight™ offers low-cost screening, providing financial relief to overwhelmed inner city healthcare systems and under-staffed rural healthcare systems.
Data Essential to Discovery
ISBRG possesses one of the most comprehensive optical datasets of its kind. Each scan strengthens our models, enhances precision and accelerates the evolution of non-invasive health screening.
Built on Real-World Evidence
From its first deployment in COVID-19 clinical trials, SpotLight™ demonstrated much stronger sensitivity than antigen tests in detecting asymptomatic infection. These results validated our approach and set the foundation for expanding non-invasive health screening to cancer and viral weaponization applications.